BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,857,723 | +162.3% | 7,680,385 | +216.6% | 0.56% | +171.2% |
| Q2 2023 | $110,518,479 | +17885.6% | 2,425,779 | +15911.7% | 0.21% | +20700.0% |
| Q1 2023 | $614,484 | +37.8% | 15,150 | +73.1% | 0.00% | 0.0% |
| Q4 2022 | $445,988 | -8.6% | 8,750 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $488,000 | -16.0% | 9,052 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $581,000 | -27.6% | 9,052 | -12.5% | 0.00% | 0.0% |
| Q1 2022 | $803,000 | -45.4% | 10,350 | -39.7% | 0.00% | -50.0% |
| Q4 2021 | $1,472,000 | -30.3% | 17,150 | -34.7% | 0.00% | -33.3% |
| Q3 2021 | $2,113,000 | +2.6% | 26,277 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $2,059,000 | -15.1% | 25,579 | -11.0% | 0.00% | -25.0% |
| Q1 2021 | $2,424,000 | +6.6% | 28,739 | +1.4% | 0.00% | 0.0% |
| Q4 2020 | $2,274,000 | +1.5% | 28,339 | +1.8% | 0.00% | -20.0% |
| Q3 2020 | $2,240,000 | -26.3% | 27,850 | -21.1% | 0.01% | -28.6% |
| Q2 2020 | $3,039,000 | -65.0% | 35,300 | -66.9% | 0.01% | -70.8% |
| Q1 2020 | $8,671,000 | -44.7% | 106,795 | -43.1% | 0.02% | -14.3% |
| Q4 2019 | $15,688,000 | -42.1% | 187,609 | -39.4% | 0.03% | -47.2% |
| Q3 2019 | $27,090,000 | -77.7% | 309,709 | -79.1% | 0.05% | -76.2% |
| Q2 2019 | $121,593,000 | -47.4% | 1,484,646 | -47.8% | 0.22% | -47.4% |
| Q1 2019 | $231,168,000 | -37.1% | 2,843,046 | -49.1% | 0.42% | -42.9% |
| Q4 2018 | $367,609,000 | -30.0% | 5,585,064 | -18.0% | 0.74% | -10.1% |
| Q3 2018 | $525,005,000 | +3.1% | 6,810,284 | -1.3% | 0.82% | +0.2% |
| Q2 2018 | $509,426,000 | +13.2% | 6,899,053 | -0.3% | 0.82% | +9.6% |
| Q1 2018 | $450,000,000 | -22.4% | 6,918,821 | -22.9% | 0.75% | -20.9% |
| Q4 2017 | $579,874,000 | -9.7% | 8,970,827 | -12.3% | 0.95% | -12.3% |
| Q3 2017 | $641,918,000 | -10.5% | 10,229,768 | -13.6% | 1.08% | -16.0% |
| Q2 2017 | $717,170,000 | -3.8% | 11,846,207 | -17.6% | 1.29% | -5.3% |
| Q1 2017 | $745,387,000 | +26.1% | 14,373,056 | +7.8% | 1.36% | +19.6% |
| Q4 2016 | $591,199,000 | +103.7% | 13,333,327 | +118.7% | 1.14% | +98.1% |
| Q3 2016 | $290,188,000 | -7.8% | 6,096,384 | -12.4% | 0.58% | -9.3% |
| Q2 2016 | $314,685,000 | +50.0% | 6,958,993 | +36.3% | 0.63% | +60.5% |
| Q1 2016 | $209,789,000 | +75093.2% | 5,106,845 | +134290.7% | 0.40% | – |
| Q4 2014 | $279,000 | -99.8% | 3,800 | -99.8% | 0.00% | -100.0% |
| Q3 2014 | $119,311,000 | -1.0% | 1,662,410 | -0.3% | 0.20% | -3.4% |
| Q2 2014 | $120,525,000 | -1.9% | 1,667,010 | -0.1% | 0.20% | -7.7% |
| Q1 2014 | $122,843,000 | +8.0% | 1,669,510 | +2.1% | 0.22% | +8.4% |
| Q4 2013 | $113,749,000 | +11.6% | 1,635,504 | +5.4% | 0.20% | +2.5% |
| Q3 2013 | $101,908,000 | +14.8% | 1,551,350 | +21.1% | 0.20% | +6.5% |
| Q2 2013 | $88,749,000 | – | 1,281,200 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |